DIPHARMA S.A.
Dipharma S.A. is a Swiss pharmaceutical company specialized in developing high quality, improved medicines for rare diseases. Dipharma S.A. is part of a third generation group of family companies grown to a global presence.
DIPHARMA S.A.
Industry:
Pharmaceutical
Address:
Chiasso, Ticino, Switzerland
Country:
Switzerland
Website Url:
http://www.dipharma.ch
Status:
Active
Contact:
+31 (0)6 31953682
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Apache Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Noscira S.A.
Noscira S.A. is a Spanish biopharmaceutical company
Current Employees Featured
Official Site Inspections
http://www.dipharma.ch
- Host name: 185.203.79.47
- IP address: 185.203.79.47
- Location: Italy
- Latitude: 43.1479
- Longitude: 12.1097
- Timezone: Europe/Rome
More informations about "Dipharma S.A."
Homepage - Dipharma SA
Dipharma SA is committed to give access to affordable and potentially improved generic drugs to patients affected by rare metabolic disorders. Discover more. People who love life. Meet Our Team. Discover more. DIPHARMA SA Piazza โฆSee details»
About us - Dipharma SA
DIPHARMA SA Piazza Col. C. Bernasconi 5 6830 Chiasso, Switzerland Phone: +41 91 60 11 700 VAT: CHE-207.217.085See details»
Who we are - Dipharma SA
Marc-Olivier Geinoz is the founder of Dipharma SA, incorporated in 2014. From 2005 until 2019, he was CEO of Dipharma Francis Srl, an API manufacturer with sales of circa $15 0 M in over โฆSee details»
About us - Dipharma CDMO and API Manufactoring
About us Dipharma is a global Contract Development and Manufacturing Organisation (CDMO) and a leading manufacturer of Active Pharmaceutical Ingredients, with more than 500 โฆSee details»
Dipharma S.A. - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number +31 (0)6 31953682 Dipharma S.A. is a Swiss pharmaceutical company specialized in developing high โฆSee details»
Dipharma SA Company Profile | Chiasso, TICINO, Switzerland ...
Find company research, competitor information, contact details & financial data for Dipharma SA of Chiasso, TICINO. Get the latest business insights from Dun & Bradstreet.See details»
Dipharma SA recognized as a Best Place to Work in Switzerland โฆ
Dec 18, 2024 By prioritizing diversity, collaboration, and employee well-being, Dipharma SA has cultivated a workplace where individuals feel valued and inspired to contribute to the โฆSee details»
Global CDMO and APIs Manufacturer
Mario Biazzi, Founder of Dipharma Group, and His Contribution to the History of Nitroglycerin. PRESS RELEASE. Read More > SHOW ALL NEWS . Upcoming events. DCAT Week 2025 โฆSee details»
Dipharma Francis S.r.l., the Shareholdersโ Meeting Appoints the โฆ
May 22, 2024 Milan, Italy โ Dipharma Francis S.r.l., (Dipharma), a global Contract Development and Manufacturing Organization (CDMO) and leading manufacturer of New Chemical Entities โฆSee details»
Dipharma SA - Drug pipelines, Patents, Clinical trials - Synapse
Oct 15, 2024 Explore Dipharma SA with its drug pipeline, therapeutic area, technology platform, .See details»
Homepage - Dipharma SA
Wir von Dipharma SA haben genau damit angefangen: mit unserem โWarumโ. Warum nicht neue Wege in der Pharmabranche beschreiten, von denen alle Beteiligten โ Patienten, Ärzte, โฆSee details»
Successful FDA Inspection at Dipharma Facility in Kalamazoo, MI, โฆ
MILAN, Italy, May 07, 2024 (GLOBE NEWSWIRE) -- Dipharma Francis S.r.l. (Dipharma), a global Contract Development and Manufacturing Organization (CDMO) and leading manufacturer of โฆSee details»
Dipharma SA - Swiss Biotech
Piazza Col. C. Bernasconi 5, Chiasso, Switzerland. Get Directions CantonSee details»
DIPHARMA IMPROVES FORMULATION OF CARGLUMIC ACID.
May 1, 2017 Carglumic acid formulation is the fourth Dipharma product approaching the market: Diterin (sapropterin dihydrochloride 100 mg tabs) has already been approved in South Korea โฆSee details»
Dipharma SA recognized for the third time as one of the best โฆ
Dec 9, 2024 Dipharma S.A. is part of a third-generation group of family-owned companies that have grown to a global presence. With a portfolio of generic orphan products for the treatment โฆSee details»
CPHI China 2025 - Dipharma
Dipharma Group team will be exhibiting at CPHI China 2025, booth N. E1H38. To book a meeting, please contact us at [email protected] Location: Shanghai New International Expo Center, โฆSee details»
Dipharma (Dipharma) - ่ฏ็ฉ็ฎก็บฟ_ไธๅฉ_ไธดๅบ่ฏ้ช_ๆ่่ฅๆถ
The Caronno Pertusella site (Italy) is the second Dipharma manufacturing facility to receive ANVISA certificationMILAN, Italy, Oct. 26, 2023 (GLOBE NEWSWIRE) -- Dipharma Francis โฆSee details»
Stoffwechselerkrankungen - Dipharma SA
DIPHARMA SA Piazza Col. C. Bernasconi 5 6830 Chiasso, Switzerland Phone: +41 91 60 11 700 VAT: CHE-207.217.085See details»
Dipharma Francis - Contatti, Prodotti e News
Dipharma Francis Srl è unโorganizzazione globale di sviluppo e produzione a contratto (CDMO) e un produttore leader di ingredienti farmaceutici attivi, con oltre 500 dipendenti, 4 stabilimenti โฆSee details»
Gaucher-krankheit - Dipharma SA
Die Gaucher-Krankheit ist eine seltene, autosomal-rezessive, genetisch bedingte Störung. Sie wird durch einen Mangel des lysosomalen Enzyms Glukozerebrosidase (auch als saure ฮฒ โฆSee details»